Differential regulation of iron chelator-induced IL-8 synthesis via MAP kinase and NF-κB in immortalized and malignant oral keratinocytes

去鐵胺

去鐵胺 （Deferoxamine ，簡稱DFOA，也可寫為desferrioxamine），以Desferal品牌在市面銷售，是一種可與鐵和鋁結合的藥物， 專門用於治療鐵中毒、因多次輸血或具有遺傳性疾病而導致的血色沉著病以及個體因.

Deferoxamine

Deferoxamine (DFOA), sold under the brand name Desferal, is a medication that binds iron and aluminium.